Related Experiment Videos
Reduced expression of erythrocyte complement receptor (C3bR) in MS
Acta Neurologica Scandinavica
|April 1, 1994
Summary
Patients with multiple sclerosis (MS) showed a higher frequency of low complement receptor expression on erythrocytes. This suggests MS disease processes, not genetics, primarily influence this reduced receptor expression.
Area of Science:
- Immunology
- Hematology
- Neurology
Background:
- Complement receptors play a role in immune responses.
- Alterations in complement receptor expression may be associated with diseases like multiple sclerosis (MS).
Purpose of the Study:
- To investigate the distribution of complement receptor phenotypes in patients with MS compared to healthy controls.
- To determine whether genetic factors or disease processes influence complement receptor expression in MS.
Main Methods:
- Classified three complement receptor phenotypes (high, medium, low) based on haemagglutination intensity and radioimmunoassay.
- Analyzed phenotype distribution in 121 MS patients and 519 controls.
- Conducted family studies to assess the influence of genetic versus disease-related factors.
Main Results:
- Observed significant differences in complement receptor phenotype distribution between MS patients and controls.
- The low complement receptor phenotype was more frequent in patients with MS.
- Family studies indicated that the disease process in MS, rather than genetic predisposition, is the primary determinant of reduced complement receptor expression.
Conclusions:
- Reduced complement receptor expression on erythrocytes is more common in MS patients.
- The observed reduction is predominantly linked to the MS disease process itself.
- This finding may have implications for understanding MS pathogenesis and potential therapeutic targets.